Literature DB >> 10833319

Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits.

R W Verwer1, K A Jansen, A A Sluiter, C W Pool, W Kamphorst, D F Swaab.   

Abstract

In the present study we have compared histochemically determined cytochrome oxidase activity with the levels of immunocytochemically stained cytochrome oxidase subunits (CO II and CO IV) and ATP synthase in the human hippocampus in relation with Alzheimer's disease. Cytochrome oxidase activity was significantly reduced in all hippocampal areas of Alzheimer patients. The protein levels of subunits II and IV were not different between control subjects and Alzheimer patients. Additionally, it was observed that the active cytochrome oxidase is evenly distributed over both cell bodies and neuropil, while a relatively large pool of inactive enzyme or precursors is limited to the neuronal somata. Further, in Alzheimer patients the CO IV immunoreactivity decreased with age, whereas in control subjects it increased with age. Our results suggest that the assembly of cytochrome oxidase or the processing of its subunits may be impaired. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833319     DOI: 10.1006/exnr.2000.7385

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

Review 1.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

Review 2.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

Review 3.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 4.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

Authors:  R H Swerdlow; S Koppel; I Weidling; C Hayley; Y Ji; H M Wilkins
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-01       Impact factor: 3.622

5.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

Authors:  Pinar E Coskun; M Flint Beal; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

6.  Discrete molecular states in the brain accompany changing responses to a vocal signal.

Authors:  Shu Dong; Kirstin L Replogle; Linda Hasadsri; Brian S Imai; Peter M Yau; Sandra Rodriguez-Zas; Bruce R Southey; Jonathan V Sweedler; David F Clayton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

7.  Brain pyrimidine nucleotide synthesis and Alzheimer disease.

Authors:  Alba Pesini; Eldris Iglesias; M Pilar Bayona-Bafaluy; Nuria Garrido-Pérez; Patricia Meade; Paula Gaudó; Irene Jiménez-Salvador; Pol Andrés-Benito; Julio Montoya; Isidro Ferrer; Pedro Pesini; Eduardo Ruiz-Pesini
Journal:  Aging (Albany NY)       Date:  2019-09-27       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.